Publication

Phase i and pharmacokinetic study of elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies

Giles, F J
; 
Vey, N
; 
Rizzieri, D
; 
Ravandi, F
; 
Prebet, T
; 
Borthakur, G
; 
Jacobsen, T F
; 
Hagen, S
; 
Nilsson, B
; 
O'Brien, S
Identifiers
http://hdl.handle.net/10379/11640
 https://doi.org/10.13025/27056
Publication Date
2012-01-06
Keywords
Type
Article
Downloads
Show all metadata
Citation
Giles, F J; Vey, N; Rizzieri, D; Ravandi, F; Prebet, T; Borthakur, G; Jacobsen, T F; Hagen, S; Nilsson, B; O'Brien, S (2012). Phase i and pharmacokinetic study of elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies. Leukemia 26 (7), 1686-1689
Abstract
Funder
Publisher
Springer Nature
Publisher DOI
Rights
Attribution-NonCommercial-NoDerivs 3.0 Ireland
cbn
Collections
Externally hosted open access publications with University of Galway authors (2)